<DOC>
	<DOCNO>NCT00546065</DOCNO>
	<brief_summary>This prospective , randomize , control , double-blinded , multi-center trial parallel-group design . Aim study evaluation tumor-free survival ablation ( APC , argon plasma coagulation ) Barrett 's mucosa plus esomeprazole versus surveillance without ablation patient cure Barrett 's cancer combine randomization esomeprazole v placebo symptomatic reflux control successful ablation Barrett 's mucosa . There two hypothesis : ( 1 ) Consecutive thermal ablation metaplastic , non-neoplastic long segment Barrett 's esophagus ( &gt; 2cm ) plus esomeprazole successful endoscopic therapy mucosal cancer mean ER decrease incidence secondary cancer ( local recurrence metachronous cancer ) minimum 50 % compare acid suppression alone without ablation within 5-years follow-up ( primary endpoint ) . ( 2 ) After successful ablation Barrett 's esophagus patient need ongoing acid suppression therapy medical control underlie reflux disease ( secondary aim study ) . Duration study : Patient recruitment period : 3 year . Follow-up period : 5 year . Total duration : 8 year . The study already recruitment period .</brief_summary>
	<brief_title>APE-Study : Ablation Barrett 's Mucosa vs. Surveillance Without Ablation Patients Cured From Barrett 's Cancer Combined With Randomization Esomeprazole v . Placebo Symptomatic Reflux Control After Successful Barrett 's Ablation</brief_title>
	<detailed_description />
	<mesh_term>Barrett Esophagus</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Endoscopically histologically complete remission mucosal Barrett 's cancer ( endoscopic resection without thermal ablation resection margin ) Initial length Barrett 's segment cancer therapy &gt; 3 cm ( initially longsegment Barrett 's esophagus ) Barrett 's length endoscopic therapy Barrett 's cancer &gt; 2 cm Informed consent patient Attempted ablation therapy trial Treatment duration early Barrett 's cancer &gt; 12 month Duration achievement complete remission attempt inclusion study &gt; 24 month The Barrett 's cancer treat already secondary lesion earlier Barrett 's cancer Inadequate healing endoscopic resection ( ER ) ulcers No residual Barrett 's mucosa observe pretreatment ER No PPI compliance Relevant comorbidity ( e.g. , malignancy ) Pregnancy Age 18 year Patient able understand study characteristics No write informed consent available Allergy esomeprazole intolerance medication ingredient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Barrett 's esophagus</keyword>
	<keyword>ablation</keyword>
	<keyword>esomeprazole</keyword>
	<keyword>Barrett 's cancer</keyword>
	<keyword>Ablation Barrett 's esophagus</keyword>
	<keyword>Surveillance Barrett 's esophagus endoscopic resection Barrett 's cancer</keyword>
	<keyword>Recurrence Barrett 's cancer</keyword>
</DOC>